Apollomics (APLM.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Apr5

Apollomics Inc. Announces Financial Report and Clinical Trial Progress for the Year Ending December 31, 2024

23:12

Apr4

Apollomics released FY2024 Q3 earnings on April 3 (EST), actual revenue USD -785K (forecast USD 0), actual EPS USD -8.4581 (forecast USD -16)

03:00

Apollomics released FY2024 9 Months Earnings on April 3, 2025 (EST), with actual revenue of USD 983K and EPS of USD -46.4581

03:00

Apollomics released FY2024 annual earnings on April 3, 2025 (EST), with actual revenue of USD 198 K (forecast USD 0) and actual EPS of USD -52.8019 (forecast USD -65)

03:00

Apollomics released FY2024 Q4 earnings on April 3 (EST), actual revenue USD -785 K (forecast USD 0), actual EPS USD -8.4581 (forecast USD -14)

03:00

Apr3

Apollomics Inc. Reports 2024 Fiscal Year Financial Results and Cancer Drug Progress

20:28

Schedules & Filings

Schedules

Filings

Apr3

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue -785 K, Net Income -9.326 M, EPS -8.4581

Nov25

Reverse Stock Split(EST)

1-for-100 Reverse Stock Split

Aug14

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 884 K, Net Income -17.6 M, EPS -19

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More